The beta-glucan market was valued at USD 307.8 million in 2016, and is expected to grow at a CAGR of 7.57%, to reach USD 476.5 million by 2022. The market is primarily driven by factors such as growing health consciousness among consumers and the increasing health expenditure. North America is projected to be the fastest-growing region as the consumers in are gradually becoming aware of the health benefits of oat beta-glucan and its significance in enhancing the body’s immunity. One of the major restraints in the growth of the beta-glucan market is the inconsistency in regulatory norms governing beta-glucan.

Pharmaceuticals segment is projected to be the fastest-growing application

The pharmaceuticals application of beta-glucan dominates the market due to its ability to cure problems such as obesity, blood pressure, and diabetes. With the increase in the quality and the arrival of clinically proven products in the market, the trust of consumers is growing for these products. The growing market for functional food & beverages is presenting opportunities for the application of beta-glucan in the food & beverage industry.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5191796

North America: High growth is expected in the beta-glucan market

North America is projected to be the fastest-growing market for the period considered for this study as the beta-glucan market here is led by its broad applications in various products, along with their health benefits. The North American region is majorly driven by the U.S. market and the increasing incidences of diseases and widespread application of fibers & specialty ingredients in various food products, beverages, and dietary supplements.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=5191796

Key Market Players

Beta-glucan market includes the profiles of leading companies such as Cargill (U.S.), Kerry Group plc (Israel), Tate & Lyle (U.K.), Royal DSM (Netherlands), Ohly (Germany), Frutarom (Israel), MilliporeSigma (U.S.), Super Beta Glucan (U.S.), and Lesaffre Human Care (France).

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
[email protected]